INHIBITORY EFFECT OF AMYLIN ON BASAL AND PARATHYROID-HORMONE STIMULATED BONE-RESORPTION IN CULTURED NEONATAL MOUSE CALVARIA

被引:22
作者
PIETSCHMANN, P
FARSOUDI, KH
HOFFMANN, O
KLAUSHOFER, K
HORANDNER, H
PETERLIK, M
机构
[1] NEUBAU AKH,DEPT GEN & EXPTL PATHOL,WAEHRINGER GUERTEL 18-20,A-1090 VIENNA,AUSTRIA
[2] ELECTRON MICROSCOPY LAB MAUER,A-1230 VIENNA,AUSTRIA
[3] UNIV VIENNA,SCH MED,DEPT GEN & EXPTL PATHOL,A-1010 VIENNA,AUSTRIA
[4] HANUSCH HOSP,LUDWIG BOLTZMANN INST OSTEOL,DEPT MED 4,A-1140 VIENNA,AUSTRIA
关键词
AMYLIN; DIABETES-ASSOCIATED PEPTIDE; BONE RESORPTION; PTH; ESCAPE PHENOMENON; NEONATAL MOUSE CALVARIA;
D O I
10.1016/8756-3282(93)90244-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Amylin is a secretory product of pancreatic beta-cells which shares major sequence homology with calcitonin gene-related peptide. In neonatal mouse calvaria maintained in organ culture for 72 h, amylin inhibited basal (i.e., unstimulated) resorption in medium concentrations above 2.5 x 10(-9) M. In addition, amylin (greater-than-or-equal-to 1.0 x 10(-7) M) in a calcitonin-like fashion transiently inhibited bone resorption induced by 1.0 x 10(-8) M PTH (''escape phenomenon''). Pretreatment of calvarial bones with amylin (1.0 x 10(-8)-1.0 X 10(-6) M) for 72 h attenuated the subsequent response to 1.0 x 10(-8) M PTH. Changes in location and appearance of osteoclasts in amylin-treated bones, as visualized by light microscopy, suggest that amylin inhibits bone resorption by causing a loss of specialized contact zones to the mineralized matrix in resorbing osteoclasts, and in addition, by preventing retraction of osteoblasts from the mineralized surface which impedes attachment of osteoclasts thereon.
引用
收藏
页码:167 / 172
页数:6
相关论文
共 26 条
  • [1] BEHAVIOR OF OSTEOCLASTS DURING A RAPID CHANGE IN THEIR NUMBER INDUCED BY HIGH-DOSES OF PARATHYROID-HORMONE OR CALCITONIN IN INTACT RATS
    BARON, R
    VIGNERY, A
    [J]. METABOLIC BONE DISEASE & RELATED RESEARCH, 1981, 2 (05): : 339 - 346
  • [2] CLARK A, 1987, LANCET, V2, P231
  • [3] PURIFICATION AND CHARACTERIZATION OF A PEPTIDE FROM AMYLOID-RICH PANCREASES OF TYPE-2 DIABETIC-PATIENTS
    COOPER, GJS
    WILLIS, AC
    CLARK, A
    TURNER, RC
    SIM, RB
    REID, KBM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) : 8628 - 8632
  • [4] INVIVO AND INVITRO EFFECTS OF AMYLIN AND AMYLIN-AMIDE ON CALCIUM-METABOLISM IN THE RAT AND RABBIT
    DATTA, HK
    ZAIDI, M
    WIMALAWANSA, SJ
    GHATEI, MA
    BEACHAM, JL
    BLOOM, SR
    MACINTYRE, I
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 162 (02) : 876 - 881
  • [5] DATTA HK, 1990, J BONE MINER RES, V5, pS229
  • [6] BONE MASS AND BONE DENSITY IN MATURITY-TYPE DIABETICS MEASURED BY I125 PHOTON-ABSORPTION TECHNIQUE
    DELEEUW, I
    ABS, R
    [J]. DIABETES, 1977, 26 (12) : 1130 - 1135
  • [7] EHRLICH JC, 1961, AM J PATHOL, V38, P49
  • [8] AMYLOID DEPOSITS AND AMYLOIDOSIS - THE BETA-FIBRILLOSES .1.
    GLENNER, GG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (23) : 1283 - 1292
  • [9] BASAL AND STIMULATED PLASMA-LEVELS OF PANCREATIC AMYLIN INDICATE ITS CO-SECRETION WITH INSULIN IN HUMANS
    HARTTER, E
    SVOBODA, T
    LUDVIK, B
    SCHULLER, M
    LELL, B
    KUENBURG, E
    BRUNNBAUER, M
    WOLOSZCZUK, W
    PRAGER, R
    [J]. DIABETOLOGIA, 1991, 34 (01) : 52 - 54
  • [10] PROSTAGLANDIN-RELATED BONE-RESORPTION IN CULTURED NEONATAL MOUSE CALVARIA - EVALUATION OF BIOPOTENCY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    HOFFMANN, O
    KLAUSHOFER, K
    KOLLER, K
    PETERLIK, M
    [J]. PROSTAGLANDINS, 1985, 30 (05): : 857 - 866